Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation
<p>Abstract</p> <p>Background</p> <p>The use of tocolytics is central in delaying birth; however, therapeutic options vary in effectiveness and adverse events profiles, which in turn could have consequences for medical resource use and cost of treatment.</p> <p...
Saved in:
Main Authors: | Connolly Mark (Author), Wex Jaro (Author), Rath Werner (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2009-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness and safety of atosiban versus conventional treatment in the management of preterm labor
by: Yan Yu, et al.
Published: (2020) -
Management of preterm labor: atosiban or nifedipine?
by: Roel de Heus, et al.
Published: (2010) -
Critical appraisal and clinical utility of atosiban in the management of preterm labor
by: Olaleye Sanu, et al.
Published: (2010) -
Tocolysis with nifedipine versus atosiban and perinatal outcome: an individual participant data meta-analysis
by: Tijn M. S. van Winden, et al.
Published: (2022) -
A prospective case-control trial to evaluate and compare the efficacy and safety of atosiban versus placebo in In vitro Fertilization-embryo transfer program
by: Vineet Mishra, et al.
Published: (2018)